Clinical Stage IIB Gastric Cancer AJCC v8
6 clinical trials · Condition
◉ Watch Clinical Stage IIB Gastric Cancer AJCC v8
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers (NCT05296005) | Ohio State University Comprehensive Cancer Center | 2025-12-31 |
| A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma (NCT04111172) | Thomas Jefferson University | 2020-11-10 |
| Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study (NCT04449679) | Thomas Jefferson University | 2020-04-15 |
| Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes (NCT04501913) | City of Hope Medical Center | 2019-12-24 |
| Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer (NCT03776487) | M.D. Anderson Cancer Center | 2019-01-07 |
| Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery (NCT03997162) | City of Hope Medical Center | 2018-10-11 |
Track Clinical Stage IIB Gastric Cancer AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.